Exact Mass: 341.1587

Exact Mass Matches: 341.1587

Found 500 metabolites which its exact mass value is equals to given mass value 341.1587, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(S)-Isocorydine

(9S)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaen-3-ol

C20H23NO4 (341.1627)


Isocorydine is an aporphine alkaloid. Isocorydine is a natural product found in Sarcocapnos saetabensis, Thalictrum delavayi, and other organisms with data available. (S)-Isocorydine is found in cherimoya. (S)-Isocorydine is an alkaloid from Peumus boldus (boldo). (S)-Isocorydine belongs to the family of Aporphines. These are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system. See also: Peumus boldus leaf (part of). (S)-Isocorydine is found in cherimoya. (S)-Isocorydine is an alkaloid from Peumus boldus (boldo Alkaloid from Peumus boldus (boldo). (S)-Isocorydine is found in cherimoya and poppy. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2324 Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1]. Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1].

   

Corydalis L

(13aS)-3,9,10-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol

C20H23NO4 (341.1627)


(S)-tetrahydrocolumbamine is a berberine alkaloid consisting of columbamine having four extra hydrogens at positions 5, 8, 13 and 13a and (S)-configuration. It is a berberine alkaloid and an organic heterotetracyclic compound. It is functionally related to a columbamine. (S)-Tetrahydrocolumbamine is a natural product found in Corydalis heterocarpa, Ceratocapnos heterocarpa, and other organisms with data available. A berberine alkaloid consisting of columbamine having four extra hydrogens at positions 5, 8, 13 and 13a and (S)-configuration. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2].

   

Corypalmine

Isoquino[2,1-b]isoquinoline, 4b,5,10,10a,11,12-hexahydro-2-hydroxy-3,8,9-tris(methoxy)-

C20H23NO4 (341.1627)


(+/-)-Corypalmine is a natural product found in Corydalis heterocarpa var. japonica, Corydalis turtschaninovii, and other organisms with data available. Corypalmine is an alkaloid from Stephania cepharantha. Corypalmine is an antifungal. Corypalmine is an alkaloid from Stephania cepharantha. Corypalmine is an antifungal.

   

Naltrexone

(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-one

C20H23NO4 (341.1627)


Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of naloxone. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. [PubChem] N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BB - Drugs used in alcohol dependence D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000427 - Alcohol Deterrents C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist CONFIDENCE standard compound; EAWAG_UCHEM_ID 2830 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Tepraloxydim

Tepraloxydim

C17H24ClNO4 (341.1394)


CONFIDENCE standard compound; INTERNAL_ID 2335 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3178

   

7-Acetylintermedine

[(1R,7AR)-1-(acetyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl (2S)-2-hydroxy-2-[(1R)-1-hydroxyethyl]-3-methylbutanoic acid

C17H27NO6 (341.1838)


7-acetylintermedine belongs to alkaloids and derivatives class of compounds. Those are naturally occurring chemical compounds that contain mostly basic nitrogen atoms. This group also includes some related compounds with neutral and even weakly acidic propertiesand is also some synthetic compounds of similar structure are attributed to alkaloids. In addition to carbon, hydrogen and nitrogen, alkaloids may also contain oxygen, sulfur and more rarely other elements such as chlorine, bromine, and phosphorus. 7-acetylintermedine is soluble (in water) and a very weakly acidic compound (based on its pKa). 7-acetylintermedine can be found in borage, which makes 7-acetylintermedine a potential biomarker for the consumption of this food product.

   
   
   

Cyclacillin

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-

C15H23N3O4S (341.1409)


Cyclacillin is only found in individuals that have used or taken this drug. It is a cyclohexylamido analog of penicillanic acid. [PubChem]The bactericidal activity of cyclacillin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cyclacillin is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01334

   

6-(alpha-D-Glucosaminyl)-1D-myo-inositol

(1R,2R,3R,4R,5S,6R)-6-{[(2R,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexane-1,2,3,4,5-pentol

C12H23NO10 (341.1322)


6-(alpha-D-Glucosaminyl)-1D-myo-inositol is a cleavage product of glycosylphosphatidylinositol phospholipase D. This enzyme catalyzes the following reaction: 6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol + H2O =. 6-(alpha-D-glucosaminyl)-1D-myo-inositol + 3-sn-phosphatidate. 6-(alpha-D-Glucosaminyl)-1D-myo-inositol is a cleavage product of glycosylphosphatidylinositol phospholipase D. This enzyme catalyzes the following reaction: 6-(alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol + H2O = Same as: G12396

   

pavine

pavine

C20H23NO4 (341.1627)


A racemate comprising equimolar amounts of (R,R)- and (S,S)-pavine.

   

7-Acetyllycopsamine

[(1R,7AR)-1-(acetyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl (2S)-2-hydroxy-2-[(1S)-1-hydroxyethyl]-3-methylbutanoic acid

C17H27NO6 (341.1838)


7-acetyllycopsamine is soluble (in water) and a very weakly acidic compound (based on its pKa). 7-acetyllycopsamine can be found in borage, which makes 7-acetyllycopsamine a potential biomarker for the consumption of this food product. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2277

   

1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside

1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside

C12H23NO10 (341.1322)


   

sulpiride

sulpiride

C15H23N3O4S (341.1409)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist CONFIDENCE standard compound; EAWAG_UCHEM_ID 3027 CONFIDENCE standard compound; INTERNAL_ID 1685 Sulpiride is an orally active dopamine D2/D3 receptor antagonist. Sulpiride is an atypical antipsychotic agent of the benzamide family. Sulpiride can be used in research into anxiety, depression and breast cancer[1][2][3].

   

Sulpiride

5-(Aminosulphonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide

C15H23N3O4S (341.1409)


Sulpiride is only found in individuals that have used or taken this drug. It is a dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)In contrast to most other neuroleptics which block both dopamine D1 and D2 receptors, Sulpiride is more selective and acts primarily as a dopamine D2 antagonist. Sulpiride appears to lack effects on norepinephrine, acetylcholine, serotonin, histamine, or gamma-aminobutyric acid (GABA) receptors. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Sulpiride is an orally active dopamine D2/D3 receptor antagonist. Sulpiride is an atypical antipsychotic agent of the benzamide family. Sulpiride can be used in research into anxiety, depression and breast cancer[1][2][3].

   

Peroxysimulenoline

2-[(2E)-4-hydroperoxy-4-methylpent-2-en-1-yl]-2,6-dimethyl-2H,5H,6H-pyrano[3,2-c]quinolin-5-one

C20H23NO4 (341.1627)


Peroxysimulenoline is found in fruits. Peroxysimulenoline is an alkaloid from the bark of Zanthoxylum simulans (Szechuan pepper

   

Mycotoxin T 2

N-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidate

C16H23NO7 (341.1474)


Isolated from seed pods of Moringa oleifera (horseradish tree). Mycotoxin T 2 is found in fats and oils, herbs and spices, and green vegetables. Mycotoxin T 2 is found in fats and oils. Mycotoxin T 2 is a mycotoxin T 2 is isolated from seed pods of Moringa oleifera (horseradish tree)

   

Histidyltryptophan

(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C17H19N5O3 (341.1488)


Histidyltryptophan is a dipeptide composed of histidine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Tryptophyl-Histidine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-(1H-imidazol-5-yl)propanoate

C17H19N5O3 (341.1488)


Tryptophyl-Histidine is a dipeptide composed of tryptophan and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Lactosamine

(2R,3R,4S,5R)-2-amino-3,5,6-trihydroxy-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexanal

C12H23NO10 (341.1322)


Lactosamine is a disaccharide composed of galactose b1,4-linked to N-acetylglucosamine, and is a common constituent of complex N-linked glycans in metazoans. Unmodified terminal lactosamine, however, is less typical in tissues, since it is often further modified by additional substitutions, such as fucose, sialic acid, or sulfate to form a number of significant receptor and signaling molecules. Lactosamine-containing glycans are also required for proper targeting and maintenance of olfactory axons, and may also function in other sensory regions.(PMID: 17111357). Isolated from human milk

   

N1-(2-Methoxy-4-methylbenzyl)-n2-(2-(5-methylpyridin-2-yl)ethyl)oxalamide

N-[(2-methoxy-4-methylphenyl)methyl]-N-[2-(5-methylpyridin-2-yl)ethyl]ethanediamide

C19H23N3O3 (341.1739)


N1-(2-Methoxy-4-methylbenzyl)-n2-(2-(5-methylpyridin-2-yl)ethyl)oxalamide is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

3,4-Dimethylideneoctanedioylcarnitine

3-[(7-carboxy-3,4-dimethylideneheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


3,4-Dimethylideneoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 3,4-dimethylideneoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3,4-Dimethylideneoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3,4-Dimethylideneoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2,3-Dimethylideneoctanedioylcarnitine

3-[(7-carboxy-2,3-dimethylideneheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


2,3-Dimethylideneoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 2,3-dimethylideneoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2,3-Dimethylideneoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2,3-Dimethylideneoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-5,8-dienedioylcarnitine

3-[(9-carboxynona-5,8-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-5,8-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-5,8-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-5,8-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-5,8-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2Z,4E)-Deca-2,4-dienedioylcarnitine

3-[(9-carboxynona-2,4-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


(2Z,4E)-Deca-2,4-dienedioylcarnitine is an acylcarnitine. More specifically, it is an (2Z,4E)-deca-2,4-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2Z,4E)-Deca-2,4-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2Z,4E)-Deca-2,4-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-3,8-dienedioylcarnitine

3-[(9-carboxynona-3,8-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-3,8-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-3,8-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-3,8-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-3,8-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-2,8-dienedioylcarnitine

3-[(9-carboxynona-2,8-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-2,8-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-2,8-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-2,8-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-2,8-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-4,7-dienedioylcarnitine

3-[(9-carboxynona-4,7-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-4,7-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-4,7-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-4,7-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-4,7-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-5,7-dienedioylcarnitine

3-[(9-carboxynona-5,7-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-5,7-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-5,7-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-5,7-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-5,7-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-4,6-dienedioylcarnitine

3-[(9-carboxynona-4,6-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-4,6-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-4,6-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-4,6-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-4,6-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-4,8-dienedioylcarnitine

3-[(9-carboxynona-4,8-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-4,8-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-4,8-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-4,8-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-4,8-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Deca-3,7-dienedioylcarnitine

3-[(9-carboxynona-3,7-dienoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H27NO6 (341.1838)


Deca-3,7-dienedioylcarnitine is an acylcarnitine. More specifically, it is an deca-3,7-dienedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Deca-3,7-dienedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Deca-3,7-dienedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(+)-Thaliporphine

4,5,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-ol

C20H23NO4 (341.1627)


   

(2R,3S,4R,5R,8R,9S,10R,11R)-5-Amino-1,2,3,4,8,9,10,11-octahydroxydodecane-6,7-dione

(2R,3S,4R,5R,8R,9S,10R,11R)-5-Amino-1,2,3,4,8,9,10,11-octahydroxydodecane-6,7-dione

C12H23NO10 (341.1322)


   

(S)-Tetrahydrocolumbamine

3,4,10-trimethoxy-7,8,12b,13-tetrahydro-5H-6-azatetraphen-11-ol

C20H23NO4 (341.1627)


(-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2].

   

1-Acetylcodeine

1-{14-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-8-yl}ethan-1-one

C20H23NO4 (341.1627)


   

1-Pentyl-3-(1-naphthoyl)indole

3-(naphthalene-1-carbonyl)-1-pentyl-1H-indole

C24H23NO (341.178)


   

1H-Purine-2,6-dione, 7-(2-(ethylamino)ethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-

1H-Purine-2,6-dione, 7-(2-(ethylamino)ethyl)-3,7-dihydro-1,3-dimethyl-8-(phenylmethyl)-

C18H23N5O2 (341.1852)


   

Codeine, acetate

10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraen-14-yl acetate

C20H23NO4 (341.1627)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

Efaproxiral

2-(4-{[(3,5-dimethylphenyl)-C-hydroxycarbonimidoyl]methyl}phenoxy)-2-methylpropanoate

C20H23NO4 (341.1627)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D006401 - Hematologic Agents > D000986 - Antisickling Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D011838 - Radiation-Sensitizing Agents

   

ethyl 15-methoxy-12-oxo-2,4,11-triazatetracyclo[11.4.0.0^{2,6}.0^{7,11}]heptadeca-1(13),3,5,14,16-pentaene-5-carboxylate

Ethyl 15-methoxy-12-oxo-2,4,11-triazatetracyclo[11.4.0.0^{2,6}.0^{7,11}]heptadeca-1(13),3,5,14,16-pentaene-5-carboxylic acid

C18H19N3O4 (341.1375)


   

Fenethylline

1,3-dimethyl-7-{2-[(1-phenylpropan-2-yl)amino]ethyl}-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C18H23N5O2 (341.1852)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

Naloxazone

14-hydrazinylidene-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol

C19H23N3O3 (341.1739)


   

Nitroxazepine

9-[3-(dimethylamino)propyl]-13-nitro-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

C18H19N3O4 (341.1375)


   

Tibalosin

1-(2,3-dihydro-1-benzothiophen-5-yl)-2-[(4-phenylbutyl)amino]propan-1-ol

C21H27NOS (341.1813)


   

N-[[(5S)-3-(4,6-Dihydropyrrolo[1,2-a][4,1]benzoxazepin-8-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

N-[(3-{8-oxa-2-azatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaen-12-yl}-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide

C18H19N3O4 (341.1375)


   

(S)-Corydine

(9S)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-16-ol

C20H23NO4 (341.1627)


(s)-corydine, also known as corydine hydrochloride or corydine, (R)-isomer, is a member of the class of compounds known as aporphines. Aporphines are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof (s)-corydine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (s)-corydine can be found in barley and custard apple, which makes (s)-corydine a potential biomarker for the consumption of these food products.

   

Acetyllycopsamine

[1-(Acetyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl 2,3-dihydroxy-2-(propan-2-yl)butanoic acid

C17H27NO6 (341.1838)


Acetyllycopsamine is soluble (in water) and a very weakly acidic compound (based on its pKa). Acetyllycopsamine can be found in borage, which makes acetyllycopsamine a potential biomarker for the consumption of this food product.

   

Histidinyl-Tryptophan

2-{[2-amino-1-hydroxy-3-(3H-imidazol-4-yl)propylidene]amino}-3-(1H-indol-3-yl)propanoic acid

C17H19N5O3 (341.1488)


   

Corydine

4H-DIBENZO(DE,G)QUINOLIN-1-OL, 5,6,6A,7-TETRAHYDRO-2,10,11-TRIMETHOXY-6-METHYL-, (6AS)-

C20H23NO4 (341.1627)


Corydine is a natural product found in Zanthoxylum oxyphyllum, Aconitum orientale, and other organisms with data available.

   

(+)-Laurifoline

(+)-Laurifoline

C20H23NO4 (341.1627)


   

7-Acetylechinatine

7-O-Acetylechinatine

C17H27NO6 (341.1838)


   

CHEMBL4521450

CHEMBL4521450

C20H23NO4 (341.1627)


   

Norargemonine

O8-Demethylargemonine

C20H23NO4 (341.1627)


   

Antibiotic BU 2183D

Antibiotic BU 2183D

C12H27N3O8 (341.1798)


   

3-Acetylindicine

3-Acetylindicine

C17H27NO6 (341.1838)


   
   

Lauroscholtzine

(+)-N-Methyllaurotetanine

C20H23NO4 (341.1627)


   

Aporphin-2-ol, 1,9,10-trimethoxy-

Aporphin-2-ol, 1,9,10-trimethoxy-

C20H23NO4 (341.1627)


   
   

Norglaucin

4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2,9,10-tetramethoxy-, (S)-

C20H23NO4 (341.1627)


Norglaucin is an isoquinoline alkaloid. Norglaucin is a natural product found in Annona purpurea, Corydalis turtschaninovii, and other organisms with data available.

   

Corypalmine

(±)-Corypalmine

C20H23NO4 (341.1627)


   

Sebiferine

(+)-O-Methylflavinanthine

C20H23NO4 (341.1627)


   

(+/-)-Corydine

(+/-)-Corydine

C20H23NO4 (341.1627)


   

9-O-Desmethyl-L-THP

(-)-Tetrahydropalmatrubine

C20H23NO4 (341.1627)


   

(-)-Discretine

(-)-Discretine

C20H23NO4 (341.1627)


   

(-)-Isonorargemonine

(-)-Isonorargemonine

C20H23NO4 (341.1627)


   

Thalicmidine

2,9,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1-ol

C20H23NO4 (341.1627)


   

CHEMBL4528264

CHEMBL4528264

C20H23NO4 (341.1627)


   
   

hexopyranosyl 3-amino-3-deoxyhexopyranoside

hexopyranosyl 3-amino-3-deoxyhexopyranoside

C12H23NO10 (341.1322)


   

5,8,13,13a-Tetrahydro-2,9-dimethoxy-13-methyl-6H-dibenzo[a,g]quinolizine-3,10-diol

5,8,13,13a-Tetrahydro-2,9-dimethoxy-13-methyl-6H-dibenzo[a,g]quinolizine-3,10-diol

C20H23NO4 (341.1627)


   

Isothalisopavine

Isothalisopavine

C20H23NO4 (341.1627)


   
   

(+)-Sarcocapnine

(+)-Sarcocapnine

C20H23NO4 (341.1627)


   

Norsecocularine

Norsecocularine

C20H23NO4 (341.1627)


   

secocularidine

secocularidine

C20H23NO4 (341.1627)


   

beta-Cyclanoline

beta-Cyclanoline

C20H23NO4 (341.1627)


   
   
   

Phyllocryptine

Phyllocryptine

C20H23NO4 (341.1627)


   
   

Dihydropapaverine

Dihydropapaverine

C20H23NO4 (341.1627)


   

Fissistigine C

O-Methylpallidine

C20H23NO4 (341.1627)


   

6-Monoacetylcodeine

6-Monoacetylcodeine

C20H23NO4 (341.1627)


   

JWH 073 2-methylnaphthyl analog

JWH 073 2-methylnaphthyl analog

C24H23NO (341.178)


   
   

JWH 018

1-naphthalenyl-(1-pentyl-1H-indol-3-yl)-methanone

C24H23NO (341.178)


   

FENETHYLLINE

FENETHYLLINE

C18H23N5O2 (341.1852)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   
   

N-Methylhernagine

N-Methylhernagine

C20H23NO4 (341.1627)


   

4-Methyl-JWH-073

4-Methyl-JWH-073

C24H23NO (341.178)


   

(S)-magnoflorine

(S)-magnoflorine

C20H23NO4 (341.1627)


   

NCGC00385937-01

NCGC00385937-01

C16H23NO7 (341.1474)


   
   

Monocrotaline N-Oxide

Monocrotaline N-Oxide

C16H23NO7 (341.1474)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 173 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 163 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 153 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 143 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 133 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 123 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 113 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 103 INTERNAL_ID 103; CONFIDENCE Reference Standard (Level 1)

   

Cycloxydim-TP BH 517-TSO E/Z-isomer

Cycloxydim-TP BH 517-TSO E/Z-isomer

C17H27NO4S (341.1661)


CONFIDENCE standard compound; UCHEM_ID 4182 UCHEM_ID 4182; CONFIDENCE standard compound

   

Phellodendrine

Phellodendrine

C20H23NO4 (341.1627)


   

5-(3,4-DIMETHOXYBENZYL)-6-METHYL-5,6,7,8-TETRAHYDRO-[1,3]DIOXOLO[4,5-G]ISOQUINOLINE

5-(3,4-DIMETHOXYBENZYL)-6-METHYL-5,6,7,8-TETRAHYDRO-[1,3]DIOXOLO[4,5-G]ISOQUINOLINE

C20H23NO4 (341.1627)


   

N-acetyltyramine 1-O-beta-glucoside

N-acetyltyramine 1-O-beta-glucoside

C16H23NO7 (341.1474)


   

N-Methylstenantherine

N-Methylstenantherine

C20H23NO4 (341.1627)


   
   

4-ethyl-10,14-dihydroxy-5-(1-hydroxyethyl)-11-methoxy-12-oxa-4-aza-tricyclo[9.2.1.02,5]tetradec-1-en-3-one|phyllostictine C

4-ethyl-10,14-dihydroxy-5-(1-hydroxyethyl)-11-methoxy-12-oxa-4-aza-tricyclo[9.2.1.02,5]tetradec-1-en-3-one|phyllostictine C

C17H27NO6 (341.1838)


   

Heptylpenicillin|Na salt-Heptylpenicillin

Heptylpenicillin|Na salt-Heptylpenicillin

C17H27NO4S (341.1661)


   

Thalisopavine

Thalisopavine

C20H23NO4 (341.1627)


   

(+)-Isocorydine

(+)-Isocorydine

C20H23NO4 (341.1627)


   

Secosarcocapnidine

Secosarcocapnidine

C20H23NO4 (341.1627)


   

Norsecosarcocapnine

Norsecosarcocapnine

C20H23NO4 (341.1627)


   

SCHEMBL9976807

SCHEMBL9976807

C20H23NO4 (341.1627)


   

4-amino-4-deoxy-alpha-D-glucopyranosyl alpha-D-glucopyranoside|4-Trehalosamin

4-amino-4-deoxy-alpha-D-glucopyranosyl alpha-D-glucopyranoside|4-Trehalosamin

C12H23NO10 (341.1322)


   

B,HCl-2-Trehalosamine|B,HCL-Mannosylglucosaminide|Mannosylglucosaminide

B,HCl-2-Trehalosamine|B,HCL-Mannosylglucosaminide|Mannosylglucosaminide

C12H23NO10 (341.1322)


   
   

2-(1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-1-methyl-3,4-dihydro-1H-isoquinoline

2-(1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-1-methyl-3,4-dihydro-1H-isoquinoline

C20H23NO4 (341.1627)


   

O-Methylpallidine

O-Methylpallidine

C20H23NO4 (341.1627)


   

6,7-dihydroxy-1-methyl-N-(6-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

6,7-dihydroxy-1-methyl-N-(6-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

C16H23NO7 (341.1474)


   

CHEMBL2314745

CHEMBL2314745

C20H23NO4 (341.1627)


   

(-)-Isocorypalmine

(-)-Isocorypalmine

C20H23NO4 (341.1627)


   

(-)-isoroemerialinone

(-)-isoroemerialinone

C20H23NO4 (341.1627)


   
   

Di-Me ether-Gusanlung C

Di-Me ether-Gusanlung C

C20H23NO4 (341.1627)


   

(+)-Laurotetanine

(+)-Laurotetanine

C20H23NO4 (341.1627)


   

(3alpha,4beta)-3-(6-ethoxy-6-(4-hydroxyphenyl)methyl)-4-(4-hydroxyphenyl)-1-methylpyrrolidin-2-one|dictamnaindiol

(3alpha,4beta)-3-(6-ethoxy-6-(4-hydroxyphenyl)methyl)-4-(4-hydroxyphenyl)-1-methylpyrrolidin-2-one|dictamnaindiol

C20H23NO4 (341.1627)


   
   

SCHEMBL15942740

SCHEMBL15942740

C12H23NO10 (341.1322)


   

(S)-form-Catalpifoline|Catalpifoline|N,O-Dimethylhernovine

(S)-form-Catalpifoline|Catalpifoline|N,O-Dimethylhernovine

C20H23NO4 (341.1627)


   
   

(+_)-Isocorypalmine|(R)-Isocorypalmine|(??)-Isocorypalmine|R-Isocorypalmine

(+_)-Isocorypalmine|(R)-Isocorypalmine|(??)-Isocorypalmine|R-Isocorypalmine

C20H23NO4 (341.1627)


   

Litseglutine B

Litseglutine B

C20H23NO4 (341.1627)


   

14-hydroxyterezine D

14-hydroxyterezine D

C19H23N3O3 (341.1739)


   

Pyranose-form-6-O-(2-Amino-2-deoxy-beta-D-glucopyranoxyl)-D-galactose

Pyranose-form-6-O-(2-Amino-2-deoxy-beta-D-glucopyranoxyl)-D-galactose

C12H23NO10 (341.1322)


   

SCHEMBL15942741

SCHEMBL15942741

C12H23NO10 (341.1322)


   

ZINC71789401

ZINC71789401

C24H23NO (341.178)


   
   
   

naphthalen-2-yl(1-(pentan-2-yl)-1H-indol-3-yl)methanone

naphthalen-2-yl(1-(pentan-2-yl)-1H-indol-3-yl)methanone

C24H23NO (341.178)


   

JWH 018 N-(2,2-dimethylpropyl) isomer

JWH 018 N-(2,2-dimethylpropyl) isomer

C24H23NO (341.178)


   
   

JWH 018 2-naphthyl-N-(2,2-dimethylpropyl) isomer

JWH 018 2-naphthyl-N-(2,2-dimethylpropyl) isomer

C24H23NO (341.178)


   
   
   

DTXSID501017297

DTXSID501017297

C24H23NO (341.178)


   
   
   
   
   
   

JWH 018 N-(2-methylbutyl) isomer

JWH 018 N-(2-methylbutyl) isomer

C24H23NO (341.178)


   
   
   
   
   
   
   

JWH 018 N-(1,1-dimethylpropyl) isomer

JWH 018 N-(1,1-dimethylpropyl) isomer

C24H23NO (341.178)


   
   

JWH 018 N-(1,2-dimethylpropyl) isomer

JWH 018 N-(1,2-dimethylpropyl) isomer

C24H23NO (341.178)


   

N,N-Dimethyllindcarpine

N,N-Dimethyllindcarpine

C20H23NO4 (341.1627)


   

1,2-Dihydropapaverine

1,2-Dihydropapaverine

C20H23NO4 (341.1627)


   

Acetyllycopsamine

BUTANOIC ACID, 2,3-DIHYDROXY-2-(1-METHYLETHYL)-, (1-(ACETYLOXY)-2,3,5,7A-TETRAHYDRO-1H-PYRROLIZIN-7-YL)METHYL ESTER, (1R-(1.ALPHA.,7(2S*,3S*),7A.BETA.))-

C17H27NO6 (341.1838)


Acetyllycopsamine is a member of pyrrolizines. 7-Acetyllycopsamine is a natural product found in Echium horridum, Amsinckia menziesii, and other organisms with data available. See also: Comfrey Leaf (part of).

   

Acetylintermedine

Butanoic acid, 2,3-dihydroxy-2-(1-methylethyl)-, (1-(acetyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl)methyl ester, (1R-(1alpha,7(2S*,3R*),7abeta))-

C17H27NO6 (341.1838)


Acetylintermedine is a member of pyrrolizines. Acetylintermedine is a natural product found in Echium pininana, Oreocarya flava, and other organisms with data available.

   

Kikemanin

(13aS)-2,3,9-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-10-ol

C20H23NO4 (341.1627)


Corydalmine is a natural product found in Stephania yunnanensis, Corydalis balansae, and other organisms with data available.

   

Rogersine

4H-Dibenzo(de,g)quinolin-9-ol, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S)-

C20H23NO4 (341.1627)


N-Methyllaurotetanine is a natural product found in Thalictrum isopyroides, Annona purpurea, and other organisms with data available. See also: Peumus boldus leaf (part of).

   

2LCP0RBK6G

2H-(1,6)DIOXACYCLOUNDECINO(2,3,4-GH)PYRROLIZINE-2,6(3H)-DIONE, 4,5,8,10,12,13,13A,13B-OCTAHYDRO-4,5-DIHYDROXY-3,4,5-TRIMETHYL-, 11-OXIDE, (3R,4S,5S,13AR,13BR)-

C16H23NO7 (341.1474)


Monocrotaline N-Oxide, a monocrotaline metabolite, leads to DNA adduct formation in vivo[1].

   

JWH-018

1-Pentyl-3-(1-naphthoyl)indole

C24H23NO (341.178)


CONFIDENCE standard compound; INTERNAL_ID 1706

   

naltrexone

naltrexone

C20H23NO4 (341.1627)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BB - Drugs used in alcohol dependence D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000427 - Alcohol Deterrents C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Isocorydine

1,2,10-Trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-ol

C20H23NO4 (341.1627)


Annotation level-1 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.577 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.572

   

coumarin 338

1H,5H,11H-[1]Benzopyrano[6,7,8-ij]quinolizine-10-carboxylic acid, 2,3,6,7-tetrahydro-11-oxo-, 1,1-dimethylethyl ester

C20H23NO4 (341.1627)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.420 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.424

   

Thaliporphine

2,9,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1-ol

C20H23NO4 (341.1627)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.636 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.631 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.632

   

Dapoxetine Hydrochloride

Dapoxetine hydrochloride (Priligy)

C21H24ClNO (341.1546)


C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

(6aS)-1,2,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10-ol

NCGC00380809-01!(6aS)-1,2,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10-ol

C20H23NO4 (341.1627)


   

2,10,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1-ol

NCGC00384558-01!2,10,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1-ol

C20H23NO4 (341.1627)


   

C16H23NO7_2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-3,4-dihydroxy-3,4,5-trimethyl-, 11-oxide

NCGC00385937-01_C16H23NO7_2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione, 4,5,8,10,12,13,13a,13b-octahydro-3,4-dihydroxy-3,4,5-trimethyl-, 11-oxide

C16H23NO7 (341.1474)


   

Levosulpiride

Levosulpiride

C15H23N3O4S (341.1409)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Levosulpiride (RV-12309) is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic agent of the benzamide class.

   

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid

C16H23NO7 (341.1474)


   

S-ISOCORYDINE (+)

S-ISOCORYDINE (+)

C20H23NO4 (341.1627)


   
   

N-methylaurotetanine

N-methylaurotetanine

C20H23NO4 (341.1627)


   
   

Predicentrine

Predicentrine

C20H23NO4 (341.1627)


   

Artabotrine

Artabotrine

C20H23NO4 (341.1627)


Origin: Plant; Formula(Parent): C20H23NO4; Bottle Name:Isocorydine hydrochloride; PRIME Parent Name:Isocorydine; PRIME in-house No.:?V0334; SubCategory_DNP: Isoquinoline alkaloids, Benzylisoquinoline alkaloids (?V0334: Luteanine) Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1]. Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1].

   

(6aS)-1,2,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10-ol [IIN-based: Match]

NCGC00380809-01!(6aS)-1,2,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10-ol [IIN-based: Match]

C20H23NO4 (341.1627)


   

(6aS)-1,2,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10-ol [IIN-based on: CCMSLIB00000845813]

NCGC00380809-01!(6aS)-1,2,11-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10-ol [IIN-based on: CCMSLIB00000845813]

C20H23NO4 (341.1627)


   
   
   
   
   
   
   
   

12-Hydroxyergometrine

12-Hydroxyergometrine

C19H23N3O3 (341.1739)


   

Hydroxyergometrine M2

Hydroxyergometrine M2

C19H23N3O3 (341.1739)


   

Hydroxyergometrine M3

Hydroxyergometrine M3

C19H23N3O3 (341.1739)


   

5-Hepten-3-ynoic acid, 7-[[(3,4-dihydro-3,4-dihydroxy-1-naphthalenyl)methyl]amino]-2,2-dimethyl-

5-Hepten-3-ynoic acid, 7-[[(3,4-dihydro-3,4-dihydroxy-1-naphthalenyl)methyl]amino]-2,2-dimethyl-

C20H23NO4 (341.1627)


   

Carboxyterbinafine derivative2

Carboxyterbinafine derivative2

C20H23NO4 (341.1627)


   

PC(0:0/5:0)

3,5,8-Trioxa-4-phosphatridecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide, (R)-

C13H28NO7P (341.1603)


   

PC(0:0/5:0)[U]

3,5,8-Trioxa-4-phosphatridecan-1-aminium, 4-hydroxy-7-(hydroxymethyl)-N,N,N-trimethyl-9-oxo-, inner salt, 4-oxide

C13H28NO7P (341.1603)


   
   

JWH 073 3-methylbutyl homolog

N-(3-Methylbutyl)-3-(1-naphthoyl)-indole

C24H23NO (341.178)


   
   

His-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-5-yl)propanoic acid

C17H19N5O3 (341.1488)


A dipeptide formed from L-histidine and L-tryptophan residues.

   

TRP-His

2-[2-amino-3-(1H-imidazol-5-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C17H19N5O3 (341.1488)


   

Peroxysimulenoline

2-[(2E)-4-hydroperoxy-4-methylpent-2-en-1-yl]-2,6-dimethyl-2H,5H,6H-pyrano[3,2-c]quinolin-5-one

C20H23NO4 (341.1627)


   

N1-(2-Methoxy-4-methylbenzyl)-n2-(2-(5-methylpyridin-2-yl)ethyl)oxalamide

N-[(2-methoxy-4-methylphenyl)methyl]-N-[2-(5-methylpyridin-2-yl)ethyl]ethanediamide

C19H23N3O3 (341.1739)


   

Mycotoxin T 2

ethyl N-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)carbamate

C16H23NO7 (341.1474)


   

JWH 018-d9

JWH 018-d9

C24H23NO (341.178)


   

JWH 018 N-(1-methylbutyl) isomer

JWH 018 N-(1-methylbutyl) isomer

C24H23NO (341.178)


   

JWH 018 2-naphthyl-N-(3-methylbutyl) isomer

JWH 018 2-naphthyl-N-(3-methylbutyl) isomer

C24H23NO (341.178)


   

JWH 018 2-naphthyl-N-(1,2-dimethylpropyl) isomer

JWH 018 2-naphthyl-N-(1,2-dimethylpropyl) isomer

C24H23NO (341.178)


   

JWH 018 2-naphthyl-N-(1,1-dimethylpropyl) isomer

JWH 018 2-naphthyl-N-(1,1-dimethylpropyl) isomer

C24H23NO (341.178)


   

JWH 018 2-naphthyl-N-(1-methylbutyl) isomer

JWH 018 2-naphthyl-N-(1-methylbutyl) isomer

C24H23NO (341.178)


   

JWH 018 2-naphthyl-N-(2-methylbutyl) isomer

JWH 018 2-naphthyl-N-(2-methylbutyl) isomer

C24H23NO (341.178)


   

JWH 073 4-methylnaphthyl analog

JWH 073 4-methylnaphthyl analog

C24H23NO (341.178)


   

LPC 5:0

2-valeryl-sn-glycero-3-phosphocholine

C13H28NO7P (341.1603)


   

3-[[2-[4-(2-methylbutan-2-yl)phenoxy]acetyl]amino]benzoic acid

3-[[2-[4-(2-methylbutan-2-yl)phenoxy]acetyl]amino]benzoic acid

C20H23NO4 (341.1627)


   

N-Acetylmetoclopramide

N-Acetylmetoclopramide

C16H24ClN3O3 (341.1506)


   

Boc-L-phe(4-ph)-OH

Boc-L-phe(4-ph)-OH

C20H23NO4 (341.1627)


   

2-BOC-AMINO-3,3-DIPHENYLPROPIONICACID

2-BOC-AMINO-3,3-DIPHENYLPROPIONICACID

C20H23NO4 (341.1627)


   

METHYL 2-FLUORO-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLATE

METHYL 2-FLUORO-4-(PIPERIDINE-1-CARBONYL)-[1,1-BIPHENYL]-3-CARBOXYLATE

C20H20FNO3 (341.1427)


   

2′-O-(2-Methoxyethyl)guanosine

2′-O-(2-Methoxyethyl)guanosine

C13H19N5O6 (341.1335)


2′-O-(2-Methoxyethyl)guanosine (2'-O-MOE-rG), a 2′-O-methoxyethyl-modified nucleoside, can be produced by enzymatic conversion (adenosine deaminase) from 2′-O-(2-methoxyethyl)-2,6-diaminopurine riboside. 2′-O-(2-Methoxyethyl)guanosine neither effectively phosphorylated by cytosolic nucleoside kinases, nor are they incorporated into cellular DNA or RNA[1][2].

   

Z-D-Asp(OtBu)-OH.H2O

Z-D-Asp(OtBu)-OH.H2O

C16H23NO7 (341.1474)


   

2-Ethylhexanoate manganese

2-Ethylhexanoate manganese

C16H30MnO4 (341.1524)


   

CCT128930

CCT128930

C18H20ClN5 (341.1407)


CCT128930 is a ATP-competitive and selective inhibitor of AKT (IC50=6 nM for AKT2). CCT128930 has 28-fold selectivity over the closely related PKA kinase (IC50=168 nM) through the targeting of Met282 of AKT (Met173 of PKA-AKT chimera), as well as 20-fold selectivity over p70S6K (IC50=120 nM). Antitumor activity.

   

4-Cyanobiphenyl-4-propylbenzoate

4-Cyanobiphenyl-4-propylbenzoate

C23H19NO2 (341.1416)


   

Leminoprazole

2-(1H-benzimidazol-2-ylsulfinylmethyl)-N-methyl-N-(2-methylpropyl)aniline

C19H23N3OS (341.1562)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor

   

N-(2-chloro-6-cyanopyridin-3-yl)pivalamide

N-(2-chloro-6-cyanopyridin-3-yl)pivalamide

C16H24ClN3O3 (341.1506)


   

4H-Benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol,10-methoxy-4-(1-methyl-4-piperidinyl)-

4H-Benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol,10-methoxy-4-(1-methyl-4-piperidinyl)-

C20H23NO2S (341.1449)


   

4-((4-AMINOPHENYL)SULFONYL)-1-(TERT-BUTYLOXYCARBONYL)PIPERAZINE

4-((4-AMINOPHENYL)SULFONYL)-1-(TERT-BUTYLOXYCARBONYL)PIPERAZINE

C15H23N3O4S (341.1409)


   

Cetraxate HCl

Cetraxate hydrochloride

C17H24ClNO4 (341.1394)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents

   

Acetyldihydrocodeinone

Morphinan-6-ol,6,7-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 6-acetate, (5a)

C20H23NO4 (341.1627)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants > R05DA - Opium alkaloids and derivatives C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

Boc-D-3,3-diphenylalanine

Boc-D-3,3-diphenylalanine

C20H23NO4 (341.1627)


   

N-(Tert-Butoxycarbonyl)-3-phenyl-D-phenylalanine

N-(Tert-Butoxycarbonyl)-3-phenyl-D-phenylalanine

C20H23NO4 (341.1627)


   

2,2,2-nitrilotriethanol citrate

2,2,2-nitrilotriethanol citrate

C12H23NO10 (341.1322)


   

1,3,3-trimethyl-2-[1-(methylphenylhydrazono)ethyl]-3H-indolium chloride

1,3,3-trimethyl-2-[1-(methylphenylhydrazono)ethyl]-3H-indolium chloride

C20H24ClN3 (341.1659)


   

tert-Butyl 3-(2-(methylsulfonyl)pyrimidin-4-yl)piperidine-1-carboxylate

tert-Butyl 3-(2-(methylsulfonyl)pyrimidin-4-yl)piperidine-1-carboxylate

C15H23N3O4S (341.1409)


   

2-(4-CBZ-PIPERAZIN-1-YL)PYRIDINE-5-BORONIC ACID

2-(4-CBZ-PIPERAZIN-1-YL)PYRIDINE-5-BORONIC ACID

C17H20BN3O4 (341.1547)


   

coluracetam

coluracetam

C19H23N3O3 (341.1739)


Coluracetam (MKC-231) is a new choline absorption enhancer.

   

bucumolol hydrochloride

bucumolol hydrochloride

C17H24ClNO4 (341.1394)


   

Basic Yellow 29

Basic Yellow 29

C20H24ClN3 (341.1659)


   

Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate

Ethyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)thiazole-4-carboxylate

C15H23N3O4S (341.1409)


   

ETHYL 4-(4-METHOXYPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

ETHYL 4-(4-METHOXYPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

C18H19N3O4 (341.1375)


   

tert-butyl 4-(2-aminophenyl)sulfonylpiperazine-1-carboxylate

tert-butyl 4-(2-aminophenyl)sulfonylpiperazine-1-carboxylate

C15H23N3O4S (341.1409)


   

diethyl 2-(1-(tert-butoxycarbonyl)piperidin-4-ylidene)Malonate

diethyl 2-(1-(tert-butoxycarbonyl)piperidin-4-ylidene)Malonate

C17H27NO6 (341.1838)


   

Clobenztropine

Clobenztropine

C21H24ClNO (341.1546)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Indane-2-carboxylicacid

Indane-2-carboxylicacid

C18H28ClNO3 (341.1758)


   

N-(4-(1-AMINOETHYL)PHENYL)-6-(PYRIDIN-4-YL)QUINAZOLIN-2-AMINE

N-(4-(1-AMINOETHYL)PHENYL)-6-(PYRIDIN-4-YL)QUINAZOLIN-2-AMINE

C21H19N5 (341.164)


   
   

1-[(3,4-Dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxyisoquinoline

1-[(3,4-Dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxyisoquinoline

C20H23NO4 (341.1627)


   

Bis(3-(trimethoxysilanyl)propyl)amine

Bis(3-(trimethoxysilanyl)propyl)amine

C12H31NO6Si2 (341.169)


   

AMIPRILOSEHYDROCHLORIDE

AMIPRILOSEHYDROCHLORIDE

C14H28ClNO6 (341.1605)


   
   

4-(3-AMINOMETHYL-AZETIDIN-1-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER-2HCl

4-(3-AMINOMETHYL-AZETIDIN-1-YL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER-2HCl

C14H29Cl2N3O2 (341.1637)


   

N-(3-Butenyl) Noroxymorphone Hydrochloride

N-(3-Butenyl) Noroxymorphone Hydrochloride

C20H23NO4 (341.1627)


   
   

manganese(II) isooctanoate

manganese(II) isooctanoate

C16H30MnO4 (341.1524)


   

N-(4-Fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-(4-Fluorophenyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C19H21BFNO3 (341.1598)


   
   

Manganese bis(2-ethylhexanoate)

Manganese bis(2-ethylhexanoate)

C16H30MnO4 (341.1524)


   

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,hexanedioic acid

N-(2-aminoethyl)ethane-1,2-diamine,2-(chloromethyl)oxirane,hexanedioic acid

C13H28ClN3O5 (341.1717)


   

1-[6,7-DIMETHOXY-1-(4-METHOXY-PHENYL)-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL]-ETHANONE

1-[6,7-DIMETHOXY-1-(4-METHOXY-PHENYL)-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL]-ETHANONE

C20H23NO4 (341.1627)


   

1-[4-(4-Chlorophenyl)-1-(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)piperidin-4-Yl]methanamine

1-[4-(4-Chlorophenyl)-1-(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)piperidin-4-Yl]methanamine

C18H20ClN5 (341.1407)


   

Phendimetrazine tartrate

Phendimetrazine tartrate

C16H23NO7 (341.1474)


D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

Atropine oxide hydrochloride

Atropine oxide hydrochloride

C17H24ClNO4 (341.1394)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

(S,S)-pavine

(S,S)-pavine

C20H23NO4 (341.1627)


The (S,S)-enantiomer of pavine.

   

1-(2,3-Dihydro-1-benzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol

1-(2,3-Dihydro-1-benzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol

C21H27NOS (341.1813)


   
   

3-Propyl-1-(2-pyridinylmethylamino)-4-pyrido[1,2-a]benzimidazolecarbonitrile

3-Propyl-1-(2-pyridinylmethylamino)-4-pyrido[1,2-a]benzimidazolecarbonitrile

C21H19N5 (341.164)


   
   

JWH 018 N-(3-methylbutyl) isomer

JWH 018 N-(3-methylbutyl) isomer

C24H23NO (341.178)


   

5-[3-(Dimethylamino)propylamino]-3,10-dimethylpyrimido[4,5-b]quinoline-2,4-dione

5-[3-(Dimethylamino)propylamino]-3,10-dimethylpyrimido[4,5-b]quinoline-2,4-dione

C18H23N5O2 (341.1852)


   

N-(4-anilinophenyl)-3-(hydroxymethyl)-1-piperidinecarbothioamide

N-(4-anilinophenyl)-3-(hydroxymethyl)-1-piperidinecarbothioamide

C19H23N3OS (341.1562)


   

H-Glu-His-Gly-OH

H-Glu-His-Gly-OH

C13H19N5O6 (341.1335)


   

(1R,5S)-3beta-(4-Chlorobenzhydryloxy)tropane

(1R,5S)-3beta-(4-Chlorobenzhydryloxy)tropane

C21H24ClNO (341.1546)


   
   

N-[(1-ethyl-3-pyrrolidinyl)methyl]-2-methoxy-5-sulfamoylbenzamide

N-[(1-ethyl-3-pyrrolidinyl)methyl]-2-methoxy-5-sulfamoylbenzamide

C15H23N3O4S (341.1409)


   

9-Butyl-8-(2,5-dimethoxy-benzyl)-9H-purin-6-ylamine

9-Butyl-8-(2,5-dimethoxy-benzyl)-9H-purin-6-ylamine

C18H23N5O2 (341.1852)


   

5-Cyano-N-(2,5-dimethoxybenzyl)-6-ethoxypyridine-2-carboxamide

5-Cyano-N-(2,5-dimethoxybenzyl)-6-ethoxypyridine-2-carboxamide

C18H19N3O4 (341.1375)


   

4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid

4-Acetyl-4-guanidino-6-methyl(propyl)carboxamide-4,5-dihydro-2H-pyran-2-carboxylic acid

C14H23N5O5 (341.1699)


   

3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C21H19N5 (341.164)


   

Cyclacillin

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-

C15H23N3O4S (341.1409)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Efaproxiral

Efaproxiral

C20H23NO4 (341.1627)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D006401 - Hematologic Agents > D000986 - Antisickling Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D011838 - Radiation-Sensitizing Agents

   

483-34-1

(13aS)-3,9,10-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol

C20H23NO4 (341.1627)


(-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2]. (-)-Isocorypalmine (Tetrahydrocolumbamine), isolated from the crude base fraction of Corydalis chaerophylla, is a dopamine receptor ligand[1]. Recombinant CYP719A21 displays strict substrate specificity and high affinity (Km=4.63 ± 0.71 μM) for (-)-Isocorypalmine[2].

   

Luteanin

4H-Dibenzo(de,g)quinolin-11-ol, 5,6,6a,7-tetrahydro-1,2,10-trimethoxy-6-methyl-, (S)- (9CI)

C20H23NO4 (341.1627)


Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1]. Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1].

   

N-(4-fluorophenyl)-2-[4-(2-fluorophenyl)pyrazol-1-yl]-2-methylpropanamide

N-(4-fluorophenyl)-2-[4-(2-fluorophenyl)pyrazol-1-yl]-2-methylpropanamide

C19H17F2N3O (341.134)


   

Tetrahydropalmatrubine

Tetrahydropalmatrubine

C20H23NO4 (341.1627)


   

Heptylpenicillin

Heptylpenicillin

C16H25N2O4S- (341.1535)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2-dihydroisoquinoline

(1S)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-1,2-dihydroisoquinoline

C20H23NO4 (341.1627)


   

(R,R)-pavine

(R,R)-pavine

C20H23NO4 (341.1627)


The (R,R)-enantiomer of pavine.

   

(7Z)-7-hydrazinylidene-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol

(7Z)-7-hydrazinylidene-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol

C19H23N3O3 (341.1739)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

3,4-Dimethylideneoctanedioylcarnitine

3,4-Dimethylideneoctanedioylcarnitine

C17H27NO6 (341.1838)


   

2,3-Dimethylideneoctanedioylcarnitine

2,3-Dimethylideneoctanedioylcarnitine

C17H27NO6 (341.1838)


   

N-[[(5S)-3-(4,6-Dihydropyrrolo[1,2-a][4,1]benzoxazepin-8-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

N-[[(5S)-3-(4,6-Dihydropyrrolo[1,2-a][4,1]benzoxazepin-8-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

C18H19N3O4 (341.1375)


   

Deca-5,8-dienedioylcarnitine

Deca-5,8-dienedioylcarnitine

C17H27NO6 (341.1838)


   

Deca-3,8-dienedioylcarnitine

Deca-3,8-dienedioylcarnitine

C17H27NO6 (341.1838)


   

Deca-2,8-dienedioylcarnitine

Deca-2,8-dienedioylcarnitine

C17H27NO6 (341.1838)


   

Deca-4,7-dienedioylcarnitine

Deca-4,7-dienedioylcarnitine

C17H27NO6 (341.1838)


   

Deca-5,7-dienedioylcarnitine

Deca-5,7-dienedioylcarnitine

C17H27NO6 (341.1838)


   

Deca-4,6-dienedioylcarnitine

Deca-4,6-dienedioylcarnitine

C17H27NO6 (341.1838)


   

Deca-4,8-dienedioylcarnitine

Deca-4,8-dienedioylcarnitine

C17H27NO6 (341.1838)


   

Deca-3,7-dienedioylcarnitine

Deca-3,7-dienedioylcarnitine

C17H27NO6 (341.1838)


   

(2Z,4E)-Deca-2,4-dienedioylcarnitine

(2Z,4E)-Deca-2,4-dienedioylcarnitine

C17H27NO6 (341.1838)


   

4-Dimethylamino-2,4,6-trimethoxychalcone

4-Dimethylamino-2,4,6-trimethoxychalcone

C20H23NO4 (341.1627)


   

6-[4-(1-phenylethylamino)-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

6-[4-(1-phenylethylamino)-1H-quinazolin-2-ylidene]-1-cyclohexa-2,4-dienone

C22H19N3O (341.1528)


   

2-[4-(4-nitrophenyl)-1-piperazinyl]-N-(2-pyridinyl)acetamide

2-[4-(4-nitrophenyl)-1-piperazinyl]-N-(2-pyridinyl)acetamide

C17H19N5O3 (341.1488)


   

(4R,4aS,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one

(4R,4aS,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one

C20H23NO4 (341.1627)


   

(2R,3R,4S,5R)-2-amino-3,4,6-trihydroxy-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal

(2R,3R,4S,5R)-2-amino-3,4,6-trihydroxy-5-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal

C12H23NO10 (341.1322)


   

L-glutamyl-L-prolyl-L-proline

L-glutamyl-L-prolyl-L-proline

C15H23N3O6 (341.1587)


   

4-benzyl-N-(3-methoxyphenyl)piperazine-1-carbothioamide

4-benzyl-N-(3-methoxyphenyl)piperazine-1-carbothioamide

C19H23N3OS (341.1562)


   

3-(3,7-Dimethylocta-1,6-dien-3-yl)-5,7-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-olate

3-(3,7-Dimethylocta-1,6-dien-3-yl)-5,7-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-olate

C20H21O5- (341.1389)


   

1-(3-Chloro-4-methoxyphenyl)-3-[2-(4-methyl-1-piperidinyl)ethyl]thiourea

1-(3-Chloro-4-methoxyphenyl)-3-[2-(4-methyl-1-piperidinyl)ethyl]thiourea

C16H24ClN3OS (341.1329)


   

3-Hydroxy-2-naphthalenecarboxylic acid [2-(3,5-dimethyl-1-piperidinyl)-2-oxoethyl] ester

3-Hydroxy-2-naphthalenecarboxylic acid [2-(3,5-dimethyl-1-piperidinyl)-2-oxoethyl] ester

C20H23NO4 (341.1627)


   

3-[3-(4-Tert-butylphenoxy)propyl]-1,3-benzothiazol-2-one

3-[3-(4-Tert-butylphenoxy)propyl]-1,3-benzothiazol-2-one

C20H23NO2S (341.1449)


   

N-cyclohexyl-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]acetamide

N-cyclohexyl-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]acetamide

C20H23NO4 (341.1627)


   

N-[2-(4-methoxyphenyl)-4-oxo-1,2-dihydroquinazolin-3-yl]carbamic acid ethyl ester

N-[2-(4-methoxyphenyl)-4-oxo-1,2-dihydroquinazolin-3-yl]carbamic acid ethyl ester

C18H19N3O4 (341.1375)


   

3-(4-ethoxyphenyl)-N-[(1-methyl-4-piperidinylidene)amino]-1H-pyrazole-5-carboxamide

3-(4-ethoxyphenyl)-N-[(1-methyl-4-piperidinylidene)amino]-1H-pyrazole-5-carboxamide

C18H23N5O2 (341.1852)


   

3-Pyridinecarboxylic acid [4-[heptoxy(oxo)methyl]phenyl] ester

3-Pyridinecarboxylic acid [4-[heptoxy(oxo)methyl]phenyl] ester

C20H23NO4 (341.1627)


   

N-[(E)-2,3-dihydro-1,4-benzodioxin-6-ylmethylideneamino]-2-(4-methoxyanilino)acetamide

N-[(E)-2,3-dihydro-1,4-benzodioxin-6-ylmethylideneamino]-2-(4-methoxyanilino)acetamide

C18H19N3O4 (341.1375)


   

N-[(E)-1-[4-[(2,2,2-Trifluoroacetyl)amino]phenyl]ethylideneamino]cyclopentanecarboxamide

N-[(E)-1-[4-[(2,2,2-Trifluoroacetyl)amino]phenyl]ethylideneamino]cyclopentanecarboxamide

C16H18F3N3O2 (341.1351)


   

2-methoxy-6-((E)-{[4-(2-methoxyphenyl)-1-piperazinyl]imino}methyl)phenol

2-methoxy-6-((E)-{[4-(2-methoxyphenyl)-1-piperazinyl]imino}methyl)phenol

C19H23N3O3 (341.1739)


   

N-(1,3-benzodioxol-5-ylmethyl)-6-morpholin-4-ylpyridine-3-carboxamide

N-(1,3-benzodioxol-5-ylmethyl)-6-morpholin-4-ylpyridine-3-carboxamide

C18H19N3O4 (341.1375)


   
   
   
   
   

Galbeta1-3GlcNH2

Galbeta1-3GlcNH2

C12H23NO10 (341.1322)


   

(1R,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aS,8bS)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C19H20FN3O2 (341.1539)


   

1-[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-1-butanone

1-[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-1-butanone

C19H23N3O3 (341.1739)


   

(1S,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1R,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1R,2aR,8bR)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1S,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

(1S,2aS,8bS)-N-(3-fluorophenyl)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-2-carboxamide

C19H20FN3O2 (341.1539)


   

(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C19H20FN3O2 (341.1539)


   

(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aR,8bR)-N-(2-fluorophenyl)-1-(hydroxymethyl)-2-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C19H20FN3O2 (341.1539)


   

1-[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-1-butanone

1-[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxazolylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-1-butanone

C19H23N3O3 (341.1739)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Gal(b1-3)b-GlcN

Gal(b1-3)b-GlcN

C12H23NO10 (341.1322)


   

D-galacto-hexopyranosyl 2-amino-2-deoxy-D-gluco-hexopyranoside

D-galacto-hexopyranosyl 2-amino-2-deoxy-D-gluco-hexopyranoside

C12H23NO10 (341.1322)


   

6-tert-butyl-N-[(E)-(1-methylpyrrol-2-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

6-tert-butyl-N-[(E)-(1-methylpyrrol-2-yl)methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C19H23N3O3 (341.1739)


   

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octanoate

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octanoate

C13H28NO7P (341.1603)


   

(2-Hydroxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hydroxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C13H28NO7P (341.1603)


   

Ciclacillin

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-[[(1-aminocyclohexyl)carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)-

C15H23N3O4S (341.1409)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D01334

   

6-(alpha-D-Glucosaminyl)-1D-myo-inositol

6-(alpha-D-Glucosaminyl)-1D-myo-inositol

C12H23NO10 (341.1322)


A D-glucosaminide consisting of 2-aminoglucosamine attached to 1D-myo-inositol at the 6-position via an alpha-linkage. Same as: G12396

   

(+/-)-Isocorypalmine

(+/-)-Isocorypalmine

C20H23NO4 (341.1627)


   

ethyl 15-methoxy-12-oxo-2,4,11-triazatetracyclo[11.4.0.0^{2,6}.0^{7,11}]heptadeca-1(13),3,5,14,16-pentaene-5-carboxylate

ethyl 15-methoxy-12-oxo-2,4,11-triazatetracyclo[11.4.0.0^{2,6}.0^{7,11}]heptadeca-1(13),3,5,14,16-pentaene-5-carboxylate

C18H19N3O4 (341.1375)


   
   

3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

C20H23NO4 (341.1627)


   

2-valeryl-sn-glycero-3-phosphocholine

2-valeryl-sn-glycero-3-phosphocholine

C13H28NO7P (341.1603)


   

Lactosamine

Lactosamine

C12H23NO10 (341.1322)


A disaccharide that consists of D-glucosamine having a beta-D-galactosyl residue attached at position 4.

   

3-linalylflaviolin-2-olate

3-linalylflaviolin-2-olate

C20H21O5 (341.1389)


An organic anion that is the conjugate base of 3-linalylflaviolin, obtained by deprotonation of the 2-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   
   

2,3,8,9-tetramethoxy-5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene

2,3,8,9-tetramethoxy-5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene

C20H23NO4 (341.1627)


An isoquinoline alkaloid that is 5,6,11,12-tetrahydro-5,11-epiminodibenzo[a,e][8]annulene substituted at positions 2, 3, 8 and 9 by methoxy groups.

   
   
   
   

ST 18:5;O2;Gly

ST 18:5;O2;Gly

C20H23NO4 (341.1627)


   

L-655708

L-655708

C18H19N3O4 (341.1375)


L-655708 is a potent α5 subunit-selective GABAA receptor inverse agonist (Ki=0.45 nM).

   

(1r,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-5-ol

(1r,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-5-ol

C20H23NO4 (341.1627)


   

(1e,5r,10s,11s,14s)-4-ethyl-10,14-dihydroxy-5-[(1s)-1-hydroxyethyl]-11-methoxy-12-oxa-4-azatricyclo[9.2.1.0²,⁵]tetradec-1-en-3-one

(1e,5r,10s,11s,14s)-4-ethyl-10,14-dihydroxy-5-[(1s)-1-hydroxyethyl]-11-methoxy-12-oxa-4-azatricyclo[9.2.1.0²,⁵]tetradec-1-en-3-one

C17H27NO6 (341.1838)


   

6-hydroxy-7-(2-methylpropyl)-4-(2-methylpropylidene)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

6-hydroxy-7-(2-methylpropyl)-4-(2-methylpropylidene)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C19H23N3O3 (341.1739)


   

[(7r)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

[(7r)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C17H27NO6 (341.1838)


   

(2r,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2r,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C12H23NO10 (341.1322)


   

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 3-(acetyloxy)-2-hydroxy-2-isopropylbutanoate

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 3-(acetyloxy)-2-hydroxy-2-isopropylbutanoate

C17H27NO6 (341.1838)


   

2-bromo-6-[(dimethylamino)methyl]-4-(2,4,4-trimethylpentan-2-yl)phenol

2-bromo-6-[(dimethylamino)methyl]-4-(2,4,4-trimethylpentan-2-yl)phenol

C17H28BrNO (341.1354)


   

5,6,17-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3(8),4,6,14(18),15-hexaene

5,6,17-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3(8),4,6,14(18),15-hexaene

C20H23NO4 (341.1627)


   

7-[2-(dimethylamino)ethyl]-13,14-dimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaen-4-ol

7-[2-(dimethylamino)ethyl]-13,14-dimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaen-4-ol

C20H23NO4 (341.1627)


   

4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

C20H23NO4 (341.1627)


   

(1s,9s)-4,5,13-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10,13-pentaen-12-one

(1s,9s)-4,5,13-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10,13-pentaen-12-one

C20H23NO4 (341.1627)


   

(1s,4s,7s,9r)-6,9-dihydroxy-4-methyl-1-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1s,4s,7s,9r)-6,9-dihydroxy-4-methyl-1-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C19H23N3O3 (341.1739)


   

5-[(3,4-dimethoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline

5-[(3,4-dimethoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline

C20H23NO4 (341.1627)


   

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidic acid

n-({4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}methyl)ethoxycarboximidic acid

C16H23NO7 (341.1474)


   

2-(4-hydroperoxy-4-methylpent-2-en-1-yl)-2,6-dimethylpyrano[3,2-c]quinolin-5-one

2-(4-hydroperoxy-4-methylpent-2-en-1-yl)-2,6-dimethylpyrano[3,2-c]quinolin-5-one

C20H23NO4 (341.1627)


   

(2r)-2-[(2e)-4-hydroperoxy-4-methylpent-2-en-1-yl]-2,6-dimethylpyrano[3,2-c]quinolin-5-one

(2r)-2-[(2e)-4-hydroperoxy-4-methylpent-2-en-1-yl]-2,6-dimethylpyrano[3,2-c]quinolin-5-one

C20H23NO4 (341.1627)


   

(2s,3r,4s,5s)-3,6-diamino-4-{[(2r,5s)-5-amino-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,5-triol

(2s,3r,4s,5s)-3,6-diamino-4-{[(2r,5s)-5-amino-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,5-triol

C12H27N3O8 (341.1798)


   

[(7s,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

[(7s,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C17H27NO6 (341.1838)


   

(5s,12br)-3,10-dimethoxy-5-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-2,11-diol

(5s,12br)-3,10-dimethoxy-5-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-2,11-diol

C20H23NO4 (341.1627)


   

(4z,7s)-6-hydroxy-7-(2-methylpropyl)-4-(2-methylpropylidene)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

(4z,7s)-6-hydroxy-7-(2-methylpropyl)-4-(2-methylpropylidene)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one

C19H23N3O3 (341.1739)


   

3'-acetylechinatine

NA

C17H27NO6 (341.1838)


{"Ingredient_id": "HBIN007876","Ingredient_name": "3'-acetylechinatine","Alias": "NA","Ingredient_formula": "C17H27NO6","Ingredient_Smile": "CC(C)C(C(C)OC(=O)C)(C(=O)OCC1=CCN2C1C(CC2)O)O","Ingredient_weight": "341.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37200","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101924036","DrugBank_id": "NA"}

   

3'-acetylrinderine

NA

C17H27NO6 (341.1838)


{"Ingredient_id": "HBIN007882","Ingredient_name": "3'-acetylrinderine","Alias": "NA","Ingredient_formula": "C17H27NO6","Ingredient_Smile": "CC(C)C(C(C)OC(=O)C)(C(=O)OCC1=CCN2C1C(CC2)O)O","Ingredient_weight": "341.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37198","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101993113","DrugBank_id": "NA"}

   

6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline

NA

C16H23NO7 (341.1474)


{"Ingredient_id": "HBIN012063","Ingredient_name": "6,7-dihydroxy-1-methyl-n-(6'-fructopyranosyl)-1,2,3,4-tetrahydroisoquinoline","Alias": "NA","Ingredient_formula": "C16H23NO7","Ingredient_Smile": "CC1C2=CC(=C(C=C2CCN1C3(C(C(C(CO3)O)O)O)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6032","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

7-Acetyllycops-amine

NA

C17H27NO6 (341.1838)


{"Ingredient_id": "HBIN013023","Ingredient_name": "7-Acetyllycops-amine","Alias": "NA","Ingredient_formula": "C17H27NO6","Ingredient_Smile": "CC(C)C(C(C)O)(C(=O)OCC1=CCN2C1C(CC2)OC(=O)C)O","Ingredient_weight": "341.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37733","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "91747347","DrugBank_id": "NA"}

   

acetylindicine

NA

C17H27NO6 (341.1838)


{"Ingredient_id": "HBIN014477","Ingredient_name": "acetylindicine","Alias": "NA","Ingredient_formula": "C17H27NO6","Ingredient_Smile": "CC(C)C(C(C)OC(=O)C)(C(=O)OCC1=CCN2C1C(CC2)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "437","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(3s,6s)-3-({1-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]indol-3-yl}methyl)-6-methyl-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-({1-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]indol-3-yl}methyl)-6-methyl-3,6-dihydropyrazine-2,5-diol

C19H23N3O3 (341.1739)


   

(3s,4s)-3-[(r)-ethoxy(4-hydroxyphenyl)methyl]-4-(4-hydroxyphenyl)-1-methylpyrrolidin-2-one

(3s,4s)-3-[(r)-ethoxy(4-hydroxyphenyl)methyl]-4-(4-hydroxyphenyl)-1-methylpyrrolidin-2-one

C20H23NO4 (341.1627)


   

(9r)-5,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

(9r)-5,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

C20H23NO4 (341.1627)


   

12-[2-(dimethylamino)ethyl]-5,15-dimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-4-ol

12-[2-(dimethylamino)ethyl]-5,15-dimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-4-ol

C20H23NO4 (341.1627)


   

6-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexane-1,2,3,4,5-pentol

6-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexane-1,2,3,4,5-pentol

C12H23NO10 (341.1322)


   

(4bs,6ar,10ar,10br)-8-hydroxy-4b-(hydroxymethyl)-7,10a-dimethyl-5h,6h,6ah,10h,10bh,11h-naphtho[1,2-h]isoquinoline-9,12-dione

(4bs,6ar,10ar,10br)-8-hydroxy-4b-(hydroxymethyl)-7,10a-dimethyl-5h,6h,6ah,10h,10bh,11h-naphtho[1,2-h]isoquinoline-9,12-dione

C20H23NO4 (341.1627)


   

(9s)-3-hydroxy-4,15-dimethoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-16-olate

(9s)-3-hydroxy-4,15-dimethoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-16-olate

C20H23NO4 (341.1627)


   

(1r,9r)-4,5,13-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10,13-pentaen-12-one

(1r,9r)-4,5,13-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10,13-pentaen-12-one

C20H23NO4 (341.1627)


   

6,9-dihydroxy-4-methyl-1-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

6,9-dihydroxy-4-methyl-1-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C19H23N3O3 (341.1739)


   

(10s)-4,5,17-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,14(18),15-hexaene

(10s)-4,5,17-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,14(18),15-hexaene

C20H23NO4 (341.1627)


   

(9s)-4,5,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

(9s)-4,5,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

C20H23NO4 (341.1627)


   

4,5,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

4,5,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

C20H23NO4 (341.1627)


   

(1s,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

(1s,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

C20H23NO4 (341.1627)


   

(9s)-3,4,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

(9s)-3,4,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

C20H23NO4 (341.1627)


   

(1r,9s)-4,5,13-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10,13-pentaen-12-one

(1r,9s)-4,5,13-trimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10,13-pentaen-12-one

C20H23NO4 (341.1627)


   

5,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

5,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

C20H23NO4 (341.1627)


   

(1s,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

(1s,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

C20H23NO4 (341.1627)


   

(5r)-5-[(3,4-dimethoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline

(5r)-5-[(3,4-dimethoxyphenyl)methyl]-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline

C20H23NO4 (341.1627)


   

(9r)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

(9r)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

C20H23NO4 (341.1627)


   

(2s,3s)-n-[(2s)-1-(3-chloro-4-hydroxyphenyl)-3-oxopentan-2-yl]-2-hydroxy-3-methylpentanimidic acid

(2s,3s)-n-[(2s)-1-(3-chloro-4-hydroxyphenyl)-3-oxopentan-2-yl]-2-hydroxy-3-methylpentanimidic acid

C17H24ClNO4 (341.1394)


   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2-[(1r)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2-[(1r)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

C17H27NO6 (341.1838)


   

(1s,4's)-3,10',11'-trimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,5,8'(12'),9'-pentaen-4-one

(1s,4's)-3,10',11'-trimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,5,8'(12'),9'-pentaen-4-one

C20H23NO4 (341.1627)


   

{7-[(2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxybutanoate

{7-[(2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl}methyl 2,3-dihydroxybutanoate

C17H27NO6 (341.1838)


   

(12br)-4,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-3-ol

(12br)-4,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-3-ol

C20H23NO4 (341.1627)


   

2,3,10-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

2,3,10-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C20H23NO4 (341.1627)


   

(2s,3r,4s)-2-heptyl-3,4-dihydroxy-3-(hydroxymethyl)-6-methoxy-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

(2s,3r,4s)-2-heptyl-3,4-dihydroxy-3-(hydroxymethyl)-6-methoxy-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

C17H27NO6 (341.1838)


   

(9s)-5,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

(9s)-5,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

C20H23NO4 (341.1627)


   

3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

C20H23NO4 (341.1627)


   

(9s)-3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

(9s)-3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

C20H23NO4 (341.1627)


   

(1r,9r)-5,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-4-ol

(1r,9r)-5,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-4-ol

C20H23NO4 (341.1627)


   

4,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-3-ol

4,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-3-ol

C20H23NO4 (341.1627)


   

(12br)-2,3,10-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

(12br)-2,3,10-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C20H23NO4 (341.1627)


   

(+)-isocorypalmine

(+)-isocorypalmine

C20H23NO4 (341.1627)


   

(12bs)-4,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-3-ol

(12bs)-4,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-3-ol

C20H23NO4 (341.1627)


   

(12bs)-10-(hydroxymethyl)-3,4-dimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

(12bs)-10-(hydroxymethyl)-3,4-dimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C20H23NO4 (341.1627)


   

(9s)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

(9s)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

C20H23NO4 (341.1627)


   

(2r,3r,4s,5r,6r)-2-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C12H23NO10 (341.1322)


   

(12bs)-2,3,10-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

(12bs)-2,3,10-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C20H23NO4 (341.1627)


   
   

(9r)-14,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-3-ol

(9r)-14,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-3-ol

C20H23NO4 (341.1627)


   

(1r,4's)-3,10',11'-trimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,5,8'(12'),9'-pentaen-4-one

(1r,4's)-3,10',11'-trimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,5,8'(12'),9'-pentaen-4-one

C20H23NO4 (341.1627)


   

(12bs)-3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

(12bs)-3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

C20H23NO4 (341.1627)


   

n-[1-(3-chloro-4-hydroxyphenyl)-3-oxopentan-2-yl]-2-hydroxy-3-methylpentanimidic acid

n-[1-(3-chloro-4-hydroxyphenyl)-3-oxopentan-2-yl]-2-hydroxy-3-methylpentanimidic acid

C17H24ClNO4 (341.1394)


   

(9s)-4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

(9s)-4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

C20H23NO4 (341.1627)


   

4,5,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

4,5,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

C20H23NO4 (341.1627)


   

4-ethyl-10,14-dihydroxy-5-(1-hydroxyethyl)-11-methoxy-12-oxa-4-azatricyclo[9.2.1.0²,⁵]tetradec-1-en-3-one

4-ethyl-10,14-dihydroxy-5-(1-hydroxyethyl)-11-methoxy-12-oxa-4-azatricyclo[9.2.1.0²,⁵]tetradec-1-en-3-one

C17H27NO6 (341.1838)


   

15,16-bis(hydroxymethyl)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

15,16-bis(hydroxymethyl)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

C20H23NO4 (341.1627)


   

4,11-dimethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-3,10-diol

4,11-dimethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-3,10-diol

C20H23NO4 (341.1627)


   

(9r)-4,5,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

(9r)-4,5,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-15-ol

C20H23NO4 (341.1627)


   

(10s)-5,6,17-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3(8),4,6,14(18),15-hexaene

(10s)-5,6,17-trimethoxy-11-methyl-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3(8),4,6,14(18),15-hexaene

C20H23NO4 (341.1627)


   

4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

C20H23NO4 (341.1627)


   

(9s)-15,16-bis(hydroxymethyl)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

(9s)-15,16-bis(hydroxymethyl)-4-methoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-3-ol

C20H23NO4 (341.1627)


   

3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-4-ol

3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-4-ol

C20H23NO4 (341.1627)


   

4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

C20H23NO4 (341.1627)


   

(12bs)-2,3,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-10-ol

(12bs)-2,3,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-10-ol

C20H23NO4 (341.1627)


   

2,3,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-12-ol

2,3,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-12-ol

C20H23NO4 (341.1627)


   

n-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

n-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C16H23NO7 (341.1474)


   

[(7r)-7-[(2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2,3-dihydroxybutanoate

[(7r)-7-[(2-methylbutanoyl)oxy]-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl 2,3-dihydroxybutanoate

C17H27NO6 (341.1838)


   

methyl(2-{4,14,15-trimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaen-7-yl}ethyl)amine

methyl(2-{4,14,15-trimethoxy-2-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaen-7-yl}ethyl)amine

C20H23NO4 (341.1627)


   

3-{[1-(4-hydroxy-3-methylbut-2-en-1-yl)indol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol

3-{[1-(4-hydroxy-3-methylbut-2-en-1-yl)indol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol

C19H23N3O3 (341.1739)


   

(1r)-2-(2h-1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinoline

(1r)-2-(2h-1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinoline

C20H23NO4 (341.1627)


   

4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

C20H23NO4 (341.1627)


   

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid

n-[(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)methyl]ethoxycarboximidic acid

C16H23NO7 (341.1474)


   

[(7s,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

[(7s,7ar)-7-(acetyloxy)-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2-[(1r)-1-hydroxyethyl]-3-methylbutanoate

C17H27NO6 (341.1838)


   

3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-2-ol

C20H23NO4 (341.1627)


   

(1s,9s)-5,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-4-ol

(1s,9s)-5,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-4-ol

C20H23NO4 (341.1627)


   

n-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

n-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]ethanimidic acid

C16H23NO7 (341.1474)


   

4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

C20H23NO4 (341.1627)


   

2-heptyl-3,4-dihydroxy-3-(hydroxymethyl)-6-methoxy-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

2-heptyl-3,4-dihydroxy-3-(hydroxymethyl)-6-methoxy-7-methylidene-2h,4h-pyrano[2,3-c]pyrrol-5-one

C17H27NO6 (341.1838)


   

(9r)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

(9r)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

C20H23NO4 (341.1627)


   

(12bs)-3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-4-ol

(12bs)-3,10,11-trimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-4-ol

C20H23NO4 (341.1627)


   

3,10',11'-trimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,5,8'(12'),9'-pentaen-4-one

3,10',11'-trimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),2,5,8'(12'),9'-pentaen-4-one

C20H23NO4 (341.1627)


   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1s)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1s)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

C17H27NO6 (341.1838)


   

[(7r,7ar)-7-{[(2r)-2-methylbutanoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3s)-2,3-dihydroxybutanoate

[(7r,7ar)-7-{[(2r)-2-methylbutanoyl]oxy}-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3s)-2,3-dihydroxybutanoate

C17H27NO6 (341.1838)


   

(9s)-4-hydroxy-15,16-dimethoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-3-olate

(9s)-4-hydroxy-15,16-dimethoxy-10,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-10-ium-3-olate

C20H23NO4 (341.1627)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1s)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1s)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

C17H27NO6 (341.1838)


   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2-[(1s)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r)-2-[(1s)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

C17H27NO6 (341.1838)


   

(1s,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-5-ol

(1s,9s)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-5-ol

C20H23NO4 (341.1627)


   

(12br,13s)-4,11-dimethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-3,10-diol

(12br,13s)-4,11-dimethoxy-13-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-3,10-diol

C20H23NO4 (341.1627)


   

(1r,9r)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

(1r,9r)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

C20H23NO4 (341.1627)


   

3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-4-ol

C20H23NO4 (341.1627)


   

(1r,4s,7s,9s)-6,9-dihydroxy-4-methyl-1-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

(1r,4s,7s,9s)-6,9-dihydroxy-4-methyl-1-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one

C19H23N3O3 (341.1739)


   

(1r)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

(1r)-4,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.6.2.0²,⁷.0¹⁰,¹⁵]heptadeca-2,4,6,10(15),11,13-hexaen-3-ol

C20H23NO4 (341.1627)


   

3,4,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

3,4,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-15-ol

C20H23NO4 (341.1627)


   

11-hydroxy-3,10-dimethoxy-6-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-4-olate

11-hydroxy-3,10-dimethoxy-6-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphen-6-ium-4-olate

C20H23NO4 (341.1627)


   

2-(2h-1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinoline

2-(2h-1,3-benzodioxol-5-ylmethyl)-6,7-dimethoxy-1-methyl-3,4-dihydro-1h-isoquinoline

C20H23NO4 (341.1627)


   

3,10-dimethoxy-5-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-2,11-diol

3,10-dimethoxy-5-methyl-7,8,12b,13-tetrahydro-5h-6-azatetraphene-2,11-diol

C20H23NO4 (341.1627)


   

(2r)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-3-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propanoic acid

(2r)-2-[(4r)-1-(2,4-dihydroxybutyl)-2-iminoimidazolidin-4-yl]-3-[(2r)-4-methyl-5-oxo-2h-furan-2-yl]propanoic acid

C15H23N3O6 (341.1587)


   

10-(hydroxymethyl)-3,4-dimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

10-(hydroxymethyl)-3,4-dimethoxy-7,8,12b,13-tetrahydro-5h-6-azatetraphen-11-ol

C20H23NO4 (341.1627)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1r)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1r)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

C17H27NO6 (341.1838)


   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1r)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-[(1r)-1-(acetyloxy)ethyl]-2-hydroxy-3-methylbutanoate

C17H27NO6 (341.1838)


   

5,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-4-ol

5,12,13-trimethoxy-17-methyl-17-azatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadeca-2(7),3,5,10,12,14-hexaen-4-ol

C20H23NO4 (341.1627)


   

(9s)-4,15,16-trimethoxy-9-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-5-ol

(9s)-4,15,16-trimethoxy-9-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaen-5-ol

C20H23NO4 (341.1627)


   

1,5-dihydroxy-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazin-2-one

1,5-dihydroxy-3-methyl-6-{[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazin-2-one

C19H23N3O3 (341.1739)


   

(9r)-4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

(9r)-4,5,15,16-tetramethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaene

C20H23NO4 (341.1627)


   

(3s,6s)-3-(hydroxymethyl)-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-(hydroxymethyl)-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C19H23N3O3 (341.1739)


   

(9s)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

(9s)-4,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-5-ol

C20H23NO4 (341.1627)


   

(9s)-4,5,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

(9s)-4,5,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,13(17),14-hexaen-16-ol

C20H23NO4 (341.1627)